PolyPeptide Group AG

SWX:PPGN Stock Report

Market Cap: CHF 943.3m

PolyPeptide Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PPGN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,445,3874.38%
Institutions6,356,09819.3%
General Public6,599,72720%
Private Companies18,582,40656.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 79.16% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
56.3%
Draupnir Holding B.V.
18,582,406CHF 531.5m0%no data
5.19%
Premier Fund Managers Ltd.
1,712,407CHF 49.0m0%0.66%
3.33%
Rudolf Maag
1,100,000CHF 31.5m0%no data
3.01%
Newtyn Management, LLC
993,573CHF 28.4m0%3.59%
2.96%
BlackRock, Inc.
975,902CHF 27.9m6.27%no data
1.68%
The Vanguard Group, Inc.
555,018CHF 15.9m-0.02%no data
1.41%
UBS Asset Management AG
464,775CHF 13.3m0.08%no data
1%
Joh. Berenberg, Gossler & Co. KG, Asset Management Arm
330,624CHF 9.5m0%0.38%
0.94%
HBM Partners Ltd.
309,000CHF 8.8m0%1.01%
0.69%
Juan Gonzalez
227,842CHF 6.5m0%no data
0.45%
Norges Bank Investment Management
149,724CHF 4.3m0%no data
0.29%
ZKB Asset Management
94,660CHF 2.7m1.91%0.01%
0.29%
Deka Investment GmbH
94,100CHF 2.7m0%no data
0.24%
Dimensional Fund Advisors LP
78,411CHF 2.2m-3.25%no data
0.22%
Zürcher Kantonalbank, Investment Arm
71,156CHF 2.0m-10.9%0.02%
0.16%
A&G Fondos Sgiic S.A
53,544CHF 1.5m0%0.8%
0.15%
Schroder Investment Management Limited
50,166CHF 1.4m0%no data
0.14%
LBP AM
46,979CHF 1.3m0%0.01%
0.14%
Pictet Asset Management SA
44,602CHF 1.3m0%no data
0.13%
Driehaus Capital Management LLC
43,389CHF 1.2m0%0.01%
0.099%
State Street Global Advisors, Inc.
32,681CHF 934.7k1.33%no data
0.084%
Charles Schwab Investment Management, Inc.
27,581CHF 788.8k0%no data
0.08%
Verwaltungs & Privat Bank AG, Asset Management Arm
26,300CHF 752.2k0%0.41%
0.071%
Jane Salik
23,511CHF 672.4k0%no data
0.07%
Valiant Bank AG, Asset Management Arm
22,965CHF 656.8k0%0.07%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 13:44
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PolyPeptide Group AG is covered by 13 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Markus MayerBaader Helvea Equity Research
Volker BosseBaader Helvea Equity Research
Konstantin WiechertBaader Helvea Equity Research